Literature DB >> 19172397

The paradox of autophagy and its implication in cancer etiology and therapy.

Avital Eisenberg-Lerner1, Adi Kimchi.   

Abstract

Autophagy is a cellular self-catabolic process in which cytoplasmic constituents are sequestered in double membrane vesicles that fuse with lysosomes where they are degraded. As this catabolic activity generates energy, autophagy is often induced under nutrient limiting conditions providing a mechanism to maintain cell viability and may be exploited by cancer cells for survival under metabolic stress. However, progressive autophagy can be cytotoxic and autophagy can under certain settings substitute for apoptosis in induction of cell death. Moreover, loss of autophagy is correlated with tumorigenesis and several inducers of autophagy are tumor-suppressor genes. Thus, the relation of autophagy to cancer development is complex and depends on the genetic composition of the cell as well as on the extra-cellular stresses a cell is exposed to. In this review we describe the intricate nature of autophagy and its regulators, particularly those that have been linked to cancer. We discuss the multifaceted relation of autophagy to tumorigenesis and highlight studies supporting a role for autophagy in both tumor-suppression and tumor-progression. Finally, various autophagy-targeting therapeutic strategies for cancer treatment are presented.

Entities:  

Mesh:

Year:  2009        PMID: 19172397     DOI: 10.1007/s10495-008-0307-5

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  82 in total

1.  ER stress and autophagy: new discoveries in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridol.

Authors:  Emilia Mahoney; David M Lucas; Sneha V Gupta; Amy J Wagner; Sarah E M Herman; Lisa L Smith; Yuh-Ying Yeh; Leslie Andritsos; Jeffrey A Jones; Joseph M Flynn; Kristie A Blum; Xiaoli Zhang; Amy Lehman; Hui Kong; Metin Gurcan; Michael R Grever; Amy J Johnson; John C Byrd
Journal:  Blood       Date:  2012-06-27       Impact factor: 22.113

2.  Expression of Beclin 1 and LC3 in FIGO stage I-II cervical squamous cell carcinoma and relationship to survival.

Authors:  Weipei Zhu; Xiaohong Pan; Feng Li; Yongshen Zhang; Xueguan Lu
Journal:  Tumour Biol       Date:  2012-05-25

Review 3.  Autophagy and tumorigenesis.

Authors:  Nan Chen; Jayanta Debnath
Journal:  FEBS Lett       Date:  2009-12-24       Impact factor: 4.124

4.  Endocytosis, signaling and cancer, much more than meets the eye. Preface.

Authors:  Pier Paolo Di Fiore
Journal:  Mol Oncol       Date:  2009-06-21       Impact factor: 6.603

5.  G226, a novel epipolythiodioxopiperazine derivative, induces autophagy and caspase-dependent apoptosis in human breast cancer cells in vitro.

Authors:  Peng-xing He; Yong-sheng Che; Qiao-jun He; Yi Chen; Jian Ding
Journal:  Acta Pharmacol Sin       Date:  2014-08       Impact factor: 6.150

Review 6.  Warburg meets autophagy: cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis.

Authors:  Stephanos Pavlides; Iset Vera; Ricardo Gandara; Sharon Sneddon; Richard G Pestell; Isabelle Mercier; Ubaldo E Martinez-Outschoorn; Diana Whitaker-Menezes; Anthony Howell; Federica Sotgia; Michael P Lisanti
Journal:  Antioxid Redox Signal       Date:  2011-11-17       Impact factor: 8.401

7.  Expression pattern of autophagy-related markers in non-metastatic clear cell renal cell carcinoma: association with disease recurrence following radical nephrectomy.

Authors:  Masatomo Nishikawa; Hideaki Miyake; Bing Liu; Masato Fujisawa
Journal:  J Cancer Res Clin Oncol       Date:  2015-02-01       Impact factor: 4.553

8.  PTK6 regulates IGF-1-induced anchorage-independent survival.

Authors:  Hanna Y Irie; Yashaswi Shrestha; Laura M Selfors; Fabianne Frye; Naoko Iida; Zhigang Wang; Lihua Zou; Jun Yao; Yiling Lu; Charles B Epstein; Sridaran Natesan; Andrea L Richardson; Kornelia Polyak; Gordon B Mills; William C Hahn; Joan S Brugge
Journal:  PLoS One       Date:  2010-07-23       Impact factor: 3.240

9.  Low concentrations of diindolylmethane, a metabolite of indole-3-carbinol, protect against oxidative stress in a BRCA1-dependent manner.

Authors:  Saijun Fan; Qinghui Meng; Tapas Saha; Fazlul H Sarkar; Eliot M Rosen
Journal:  Cancer Res       Date:  2009-07-21       Impact factor: 12.701

10.  The role of autophagy in tumour development and cancer therapy.

Authors:  Mathias T Rosenfeldt; Kevin M Ryan
Journal:  Expert Rev Mol Med       Date:  2009-12-02       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.